ICH Q1B – Photostability Testing of New Drug Substances and Products
ICH Q1B – Guideline Summary ICH Q1B is a crucial regulatory guideline that focuses on the photostability testing of new drug substances and products. It addresses the potential effects of light exposure on pharmaceutical products, aiming to ensure their stability, safety, and efficacy throughout their shelf-life. Photostability testing is essential as light, particularly ultraviolet (UV)…
Read More “ICH Q1B – Photostability Testing of New Drug Substances and Products” »